|
|
|
Volumn 66, Issue 6, 1999, Pages 361-362
|
|
The number needed to be treated as a valuable parameter in interpreting clinical trial findings [3] (multiple letters)
a
|
|
Author keywords
Clinical findings
|
|
Indexed keywords
ALENDRONIC ACID;
ANALGESIC AGENT;
MISOPROSTOL;
NONSTEROID ANTIINFLAMMATORY AGENT;
CLINICAL RESEARCH;
COST BENEFIT ANALYSIS;
HIP FRACTURE;
HUMAN;
LETTER;
PARAMETER;
PATIENT CARE;
PEPTIC ULCER;
POSTMENOPAUSE;
POSTOPERATIVE PAIN;
STATISTICAL ANALYSIS;
STATISTICS;
TREATMENT FAILURE;
TREATMENT OUTCOME;
CONFIDENCE INTERVALS;
CONTROLLED CLINICAL TRIALS;
FEMALE;
HUMANS;
MALE;
RESEARCH DESIGN;
SAMPLE SIZE;
SENSITIVITY AND SPECIFICITY;
|
|
EID: 0033304217
PISSN: 11698446
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (2)
|
|
References (0)
|
